Connect with us

Hi, what are you looking for?

Oracle of  Omaha Says – Investing and Stock NewsOracle of  Omaha Says – Investing and Stock News


This British veterinary pharma stock closed 10% down on Monday

Dechra Pharmaceuticals plc (LON: DPH) ended roughly 10% down on Monday after the veterinary products company cited higher expenses and reported lower-than-expected profit for its fiscal 2022.

Dechra Pharmaceuticals’ full-year results

Profit (before tax) was £77.6 million versus the year-ago £74 million
Revenue jumped 13% on a year-over-year basis to £681.8 million
SG&A expenses climbed from £69.1 million to £178.6 million
Consensus was £90.5 million profit on £677.8 million in revenue
Declared 44.89 pence a share of dividend – up from 40.50 a share

Despite profit coming in weaker than the experts’ forecast, Dechra Pharmaceuticals is convinced it’ll outperform in fiscal 2023. “DPH” currently trades at a price-to-earnings multiple of 47.

CEO Page’s remarks

Other notable figures in the audited preliminary full-year results include a 9.4% YoY increase in underlying operating profit. Dechra Pharmaceuticals generated £163.3 million in the recently ended year. Commenting on the financial performance, CEO Ian Page said:

We’ve continued to progress on all aspects of our strategy; the product development pipeline was strengthened, material acquisitions were completed post year-end, and a new subsidiary was established in South Korea as we continue our geographical expansion.

The report arrives almost a week after the Northwich-headquartered firm said it was buying Med-Pharmex Inc for £225.81 million ($260 million) to expand its footprint in the United States. Shares are now down 35% versus the start of 2022.

The post This British veterinary pharma stock closed 10% down on Monday appeared first on Invezz.

Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Editor's Pick

    Tele2 AB today announces a new partnership with security experts EBS to deliver a secure and managed IoT connectivity solution. Tele2 will support EBS...


    Anyone who has filled up the tank of their car this year will be aware of the rollercoaster ride that the price of oil...

    Latest News

    Sen. Patrick Leahy “was not feeling well” on Thursday and was admitted to the hospital overnight for observation, his office said in a statement....

    Latest News

    Joe Manchin is forcing Democrats into a brutal choice: Take a deal now to lower the costs of health care premiums and prescription drugs,...

    Disclaimer:, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2023